These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12609769)

  • 1. Degradation of thymic humoral factor gamma2 by human plasma: involvement of angiotensin converting enzyme.
    Bramucci M; Miano A; Quassinti L; Maccari E; Murri O; Amici D
    Regul Pept; 2003 Mar; 111(1-3):199-205. PubMed ID: 12609769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of thymic humoral factor γ2 in human, rat and mouse blood: An experimental and theoretical study.
    Martignoni M; Benedetti M; Davey GP; Tipton KF; McDonald AG
    Biochim Biophys Acta Proteins Proteom; 2020 Sep; 1868(9):140467. PubMed ID: 32512181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline.
    Rieger KJ; Saez-Servent N; Papet MP; Wdzieczak-Bakala J; Morgat JL; Thierry J; Voelter W; Lenfant M
    Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):373-8. PubMed ID: 8257427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical properties of the angiotensin-converting-like enzyme from the leech Theromyzon tessulatum.
    Laurent V; Salzet M
    Peptides; 1996; 17(5):737-45. PubMed ID: 8844761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.
    Dubreuil P; Fulcrand P; Rodriguez M; Fulcrand H; Laur J; Martinez J
    Biochem J; 1989 Aug; 262(1):125-30. PubMed ID: 2554881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of thymic humoral factor gamma 2 by neutral endopeptidase (EC 3.4.24.11).
    Indig FE; Pecht M; Trainin N; Burstein Y; Blumberg S
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):891-4. PubMed ID: 1898375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence and biochemical properties of a molluscan invertebrate angiotensin-converting enzyme.
    Laurent V; Stefano G; Salzet M
    Regul Pept; 1997 Mar; 69(2):53-61. PubMed ID: 9178346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel activity of human angiotensin I converting enzyme: release of the NH2- and COOH-terminal tripeptides from the luteinizing hormone-releasing hormone.
    Skidgel RA; Erdös EG
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1025-9. PubMed ID: 2983326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.
    Araujo MC; Melo RL; Cesari MH; Juliano MA; Juliano L; Carmona AK
    Biochemistry; 2000 Jul; 39(29):8519-25. PubMed ID: 10913258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic humoral factor gamma 2: purification and amino acid sequence of an immunoregulatory peptide from calf thymus.
    Burstein Y; Buchner V; Pecht M; Trainin N
    Biochemistry; 1988 May; 27(11):4066-71. PubMed ID: 3261994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme.
    Araujo MC; Melo RI; Del Nery E; Alves MF; Juliano MA; Casarini DE; Juliano L; Carmona AK
    J Hypertens; 1999 May; 17(5):665-72. PubMed ID: 10403610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic-controlled hydrolysis of Leu-Val-Val-hemorphin-7 catalyzed by angiotensin-converting enzyme from rat brain.
    Hayakari M; Satoh K; Izumi H; Kudoh T; Asano J; Yamazaki T; Tsuchida S
    Peptides; 2003 Jul; 24(7):1075-82. PubMed ID: 14499287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
    Binevski PV; Sizova EA; Pozdnev VF; Kost OA
    FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
    Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
    J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of angiotensin I-converting enzymes from mesangial cells in culture.
    Andrade MC; Quinto BM; Carmona AK; Ribas OS; Boim MA; Schor N; Casarini DE
    J Hypertens; 1998 Dec; 16(12 Pt 2):2063-74. PubMed ID: 9886898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of angiotensin converting enzyme (ACE) activity in serum of amphibian: comparison with ACE activity of mammalian serum.
    Miano A; Bramucci M; Murri O; Quassinti L; Maccari E; Zerani M; Gobbetti A; Amici D
    Acta Physiol Scand; 1997 Jul; 160(3):277-82. PubMed ID: 9246391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.
    Azizi M; Junot C; Ezan E; Ménard J
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1066-9. PubMed ID: 11903317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.